Leslie Hughes, APRN
Psychiatric/Mental Health · Monroe, LANPI 1598381261
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 565 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,288, 3.1 times the $1,065 reported in 2021. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 565 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$1K
- Neurocrine Biosciences, Inc.$960
- Corium, LLC$903
- Johnson & Johnson$866
- Takeda Pharmaceuticals U.S.A., Inc.$725
- plus $4K from 19 others
What the payments were for
- Food & beverage$10,17699%
- Education$1011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 99 | $1,446 |
| Alkermes, Inc. | 67 | $1,139 |
| Neurocrine Biosciences, Inc. | 52 | $960 |
| Corium, LLC | 45 | $903 |
| Johnson & Johnson | 45 | $866 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $725 |
| Otsuka America Pharmaceutical, Inc. | 35 | $569 |
| Axsome Therapeutics, Inc. | 27 | $558 |
| Teva Pharmaceuticals USA, Inc. | 26 | $463 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $456 |
| Vanda Pharmaceuticals Inc. | 18 | $401 |
| Sunovion Pharmaceuticals Inc. | 18 | $381 |
| E.r. Squibb & Sons, L.L.C. | 12 | $324 |
| Lundbeck LLC | 18 | $291 |
| Indivior Inc. | 8 | $161 |
| Supernus Pharmaceuticals, Inc. | 7 | $159 |
| Idorsia Pharmaceuticals US Inc | 8 | $123 |
| Ironshore Pharmaceuticals Inc. | 4 | $83 |
| Collegium Pharmaceutical, Inc. | 5 | $79 |
| Noven Therapeutics, LLC | 3 | $59 |
| Bausch Health US, LLC | 2 | $36 |
| Eisai Inc. | 2 | $31 |
| Amgen | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,277 in reported general payments places this provider in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 12 | $78 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Monroe
- Diane Privitor DavisMonroe$9K
- Rhonda RushingMonroe$8K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.